Ceribell (CBLL) Depreciation & Amortization (CF) (2023 - 2026)
Ceribell (CBLL) posted Depreciation & Amortization (CF) of $239000.0 for Q1 2026, down 17.87% on a QoQ basis from $291000.0 in Q4 2025, and down 28.66% year-over-year from $335000.0 in Q1 2025.
Ceribell (CBLL) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Ceribell's Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $239000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 28.66% year-over-year to $239000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 2.13% YoY) and the FY2025 annual result came in at $1.3 million, up 17.53% from the prior year.
- Depreciation & Amortization (CF) was $239000.0 for Q1 2026 at Ceribell, down from $291000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $391000.0 in Q3 2025 and bottomed at $90000.0 in Q3 2023.
- A 4-year average of $276727.3 and a median of $277000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) surged 170.0% — and 2026, when it retreated 28.66%.
- Ceribell's Depreciation & Amortization (CF) stood at $233000.0 in 2023, then jumped by 56.22% to $364000.0 in 2024, then decreased by 20.05% to $291000.0 in 2025, then slipped by 17.87% to $239000.0 in 2026.
- Business Quant data shows CBLL's Depreciation & Amortization (CF) at $239000.0 in Q1 2026, $291000.0 in Q4 2025, and $391000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | 239,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 239,000.00 |
| Mar 31, 2026 | 239,000.00 |
| Dec 31, 2025 | 291,000.00 |
| Dec 31, 2025 | 291,000.00 |
| Sep 30, 2025 | 391,000.00 |
| Sep 30, 2025 | 391,000.00 |
| Jun 30, 2025 | 324,000.00 |
| Jun 30, 2025 | 324,000.00 |
| Mar 31, 2025 | 335,000.00 |
| Mar 31, 2025 | 335,000.00 |
| Dec 31, 2024 | 364,000.00 |
| Dec 31, 2024 | 364,000.00 |
| Sep 30, 2024 | 243,000.00 |
| Sep 30, 2024 | 243,000.00 |
| Jun 30, 2024 | 277,000.00 |
| Jun 30, 2024 | 277,000.00 |
| Mar 31, 2024 | 257,000.00 |
| Mar 31, 2024 | 257,000.00 |
| Dec 31, 2023 | 233,000.00 |
| Dec 31, 2023 | 233,000.00 |